Obesity: Epidemiology, Pathophysiology, and Therapeutics

Xihua Lin, Hong Li, Xihua Lin, Hong Li

Abstract

Obesity is a complex multifactorial disease that accumulated excess body fat leads to negative effects on health. Obesity continues to accelerate resulting in an unprecedented epidemic that shows no significant signs of slowing down any time soon. Raised body mass index (BMI) is a risk factor for noncommunicable diseases such as diabetes, cardiovascular diseases, and musculoskeletal disorders, resulting in dramatic decrease of life quality and expectancy. The main cause of obesity is long-term energy imbalance between consumed calories and expended calories. Here, we explore the biological mechanisms of obesity with the aim of providing actionable treatment strategies to achieve a healthy body weight from nature to nurture. This review summarizes the global trends in obesity with a special focus on the pathogenesis of obesity from genetic factors to epigenetic factors, from social environmental factors to microenvironment factors. Against this background, we discuss several possible intervention strategies to minimize BMI.

Keywords: epidemiology; epigenetics; genetics; microenvironment; obesity; pathophysiology.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2021 Lin and Li.

References

    1. Al Kibria GM. Prevalence and Factors Affecting Underweight, Overweight and Obesity Using Asian and World Health Organization Cutoffs Among Adults in Nepal: Analysis of the Demographic and Health Survey 2016. Obes Res Clin Pract (2019) 13(2):129–36. 10.1016/j.orcp.2019.01.006
    1. Mbogori T, Kimmel K, Zhang M, Kandiah J, Wang Y. Nutrition Transition and Double Burden of Malnutrition in Africa: A Case Study of Four Selected Countries With Different Social Economic Development. AIMS Public Health (2020) 7:425–39. 10.3934/publichealth.2020035
    1. Swinburn BA, Sacks G, Hall KD, McPherson K, Finegood DT, Moodie ML, et al. . The Global Obesity Pandemic: Shaped by Global Drivers and Local Environments. Lancet (2011) 378(9793):804–14. 10.1016/S0140-6736(11)60813-1
    1. WHO Consultation on Obesity (‎1999: Geneva, Switzerland) & World Health Organization . Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation. World Health Organ Tech Rep Ser (2000) 894:i–xii, 1-253.
    1. Bray GA, Kim KK, Wilding J, World Obesity Federation . Obesity: A Chronic Relapsing Progressive Disease Process. A Position Statement of the World Obesity Federation. Obes Rev (2017) 18(7):715–23. 10.1111/obr.12551
    1. Lee SJ, Shin SW. Mechanisms, Pathophysiology, and Management of Obesity. N Engl J Med (2017) 376(15):1491–2. 10.1056/NEJMc1701944
    1. Sacks FM, Bray GA, Carey VJ, Smith SR, Ryan DH, Anton SD, et al. . Comparison of Weight-Loss Diets With Different Compositions of Fat, Protein, and Carbohydrates. N Engl J Med (2009) 360(9):859–73. 10.1056/NEJMoa0804748
    1. Singer-Englar T, Barlow G, Mathur R. Obesity, Diabetes, and the Gut Microbiome: An Updated Review. Expert Rev Gastroenterol Hepatol (2019) 13(1):3–15. 10.1080/17474124.2019.1543023
    1. Singh RK, Kumar P, Mahalingam K. Molecular Genetics of Human Obesity: A Comprehensive Review. C R Biol (2017) 340(2):87–108. 10.1016/j.crvi.2016.11.007
    1. Lopomo A, Burgio E, Migliore L. Epigenetics of Obesity. Prog Mol Biol Transl Sci (2016) 140:151–84. 10.1016/bs.pmbts.2016.02.002
    1. Dubern B. Genetics and Epigenetics of Obesity: Keys to Understand. Rev Prat (2019) 69(9):1016–9.
    1. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, et al. . Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss. Arterioscler Thromb Vasc Biol (2006) 26(5):968–76. 10.1161/01.ATV.0000216787.85457.f3
    1. Kok P, Seidell JC, Meinders AE. [The Value and Limitations of the Body Mass Index (BMI) in the Assessment of the Health Risks of Overweight and Obesity]. Ned Tijdschr Geneeskd (2004) 148(48):2379–82.
    1. Løvsletten O, Jacobsen BK, Grimsgaard S, Njølstad I, Wilsgaard T, Løchen ML, et al. . Prevalence of General and Abdominal Obesity in 2015-2016 and 8-Year Longitudinal Weight and Waist Circumference Changes in Adults and Elderly: The Tromsø Study. BMJ Open (2020) 10(11):e038465. 10.1136/bmjopen-2020-038465
    1. Paley CA, Johnson MI. Abdominal Obesity and Metabolic Syndrome: Exercise as Medicine. BMC Sports Sci Med Rehabil (2018) 10:7. 10.1186/s13102-018-0097-1
    1. Ataey A, Jafarvand E, Adham D, Moradi-Asl E. The Relationship Between Obesity, Overweight, and the Human Development Index in World Health Organization Eastern Mediterranean Region Countries. J Prev Med Public Health (2020) 53(2):98–105. 10.3961/jpmph.19.100
    1. NCD Risk Factor Collaboration (NCD-RisC) . Worldwide Trends in Body-Mass Index, Underweight, Overweight, and Obesity From 1975 to 2016: A Pooled Analysis of 2416 Population-Based Measurement Studies in 128·9 Million Children, Adolescents, and Adults. Lancet (2017) 390(10113):2627–42. 10.1016/S0140-6736(17)32129-3
    1. Chen Y, Peng Q, Yang Y, Zheng S, Wang Y, Lu W. The Prevalence and Increasing Trends of Overweight, General Obesity, and Abdominal Obesity Among Chinese Adults: A Repeated Cross-Sectional Study. BMC Public Health (2019) 19(1):1293. 10.1186/s12889-019-7633-0
    1. Jia W. Obesity in China: Its Characteristics, Diagnostic Criteria, and Implications. Front Med (2015) 9(2):129–33. 10.1007/s11684-015-0387-x
    1. Wariri O, Alhassan J, Mark G, Adesiyan O, Hanson L. Trends in Obesity by Socioeconomic Status Among non-Pregnant Women Aged 15-49 Y: A Cross-Sectional, Multi-Dimensional Equity Analysis of Demographic and Health Surveys in 11 Sub-Saharan Africa Countries, 1994-2015. Int Health (2020) 0:1–10. 10.1093/inthealth/ihaa093
    1. Tydeman-Edwards R, Van Rooyen FC, Walsh CM. Obesity, Undernutrition and the Double Burden of Malnutrition in the Urban and Rural Southern Free State, South Africa. Heliyon (2018) 4(12):e00983. 10.1016/j.heliyon.2018.e00983
    1. Yoo S. Dynamic Energy Balance and Obesity Prevention. J Obes Metab Syndr (2018) 27(4):203–12. 10.7570/jomes.2018.27.4.203
    1. Duffey KJ, Gordon-Larsen P, Jacobs DR, Jr, Williams OD, Popkin BM. Differential Associations of Fast Food and Restaurant Food Consumption With 3-Y Change in Body Mass Index: The Coronary Artery Risk Development in Young Adults Study. Am J Clin Nutr (2007) 85(1):201–8. 10.1093/ajcn/85.1.201
    1. Obri A, Claret M. The Role of Epigenetics in Hypothalamic Energy Balance Control: Implications for Obesity. Cell Stress (2019) 3(7):208–20. 10.15698/cst2019.07.191
    1. Sadeghirad B, Duhaney T, Motaghipisheh S, Campbell NR, Johnston BC. Influence of Unhealthy Food and Beverage Marketing on Children's Dietary Intake and Preference: A Systematic Review and Meta-Analysis of Randomized Trials. Obes Rev (2016) 17(10):945–59. 10.1111/obr.12445
    1. Willett WC, Leibel RL. Dietary Fat Is Not a Major Determinant of Body Fat. Am J Med (2002) 113(Suppl 9B):47S–59S. 10.1016/S0002-9343(01)00992-5
    1. Fitzgerald MP, Hennigan K, O'Gorman CS, McCarron L. Obesity, Diet and Lifestyle in 9-Year-Old Children With Parentally Reported Chronic Diseases: Findings From the Growing Up in Ireland Longitudinal Child Cohort Study. Ir J Med Sci (2019) 188(1):29–34. 10.1007/s11845-018-1814-1
    1. Romero-Ibarguengoitia ME, Vadillo-Ortega F, Caballero AE, Ibarra-González I, Herrera-Rosas A, Serratos-Canales MF, et al. . Family History and Obesity in Youth, Their Effect on Acylcarnitine/Aminoacids Metabolomics and Non-Alcoholic Fatty Liver Disease (NAFLD). Structural Equation Modeling Approach. PloS One (2018) 13(2):e0193138. 10.1371/journal.pone.0193138
    1. Corica D, Aversa T, Valenzise M, Messina MF, Alibrandi A, De Luca F, et al. . Does Family History of Obesity, Cardiovascular, and Metabolic Diseases Influence Onset and Severity of Childhood Obesity. Front Endocrinol (Lausanne) (2018) 9:187. 10.3389/fendo.2018.00187
    1. Ben Slama F, Achour A, Belhadj O, Hsairi M, Oueslati M, Achour N. [Obesity and Life Style in a Population of Male School Children Aged 6 to 10 Years in Ariana (Tunisia)]. Tunis Med (2002) 80(9):542–7.
    1. Dhana K, Haines J, Liu G, Zhang C, Wang X, Field AE, et al. . Association Between Maternal Adherence to Healthy Lifestyle Practices and Risk of Obesity in Offspring: Results From Two Prospective Cohort Studies of Mother-Child Pairs in the United States. BMJ (2018) 362:k2486. 10.1136/bmj.k2486
    1. Mulligan EP, Rauh MJ, Heiderscheit B, Jenkins WL. Sports Physical Therapy Education in the United States: Where Do We Go From Here? A Survey of American Academy of Sports Physical Therapy Members. J Allied Health (2020) 49:e79–79e87.
    1. Beets MW, Wallner M, Beighle A. Defining Standards and Policies for Promoting Physical Activity in Afterschool Programs. J Sch Health (2010) 80:411–7. 10.1111/j.1746-1561.2010.00521.x
    1. Salam RA, Padhani ZA, Das JK, Shaikh AY, Hoodbhoy Z, Jeelani S, et al. . Effects of Lifestyle Modification Interventions to Prevent and Manage Child and Adolescent Obesity: A Systematic Review and Meta-Analysis. Nutrients (2020) 12(8):2208. 10.3390/nu12082208
    1. Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, et al. . The Gut Microbiota as an Environmental Factor That Regulates Fat Storage. Proc Natl Acad Sci USA (2004) 101(44):15718–23. 10.1073/pnas.0407076101
    1. Honce R, Karlsson EA, Wohlgemuth N, Estrada LD, Meliopoulos VA, Yao J, et al. . Obesity-Related Microenvironment Promotes Emergence of Virulent Influenza Virus Strains. mBio (2020) 11(2):e03341–19. 10.1128/mBio.03341-19
    1. Stappenbeck TS, Hooper LV, Gordon JI. Developmental Regulation of Intestinal Angiogenesis by Indigenous Microbes via Paneth Cells. Proc Natl Acad Sci USA (2002) 99(24):15451–5. 10.1073/pnas.202604299
    1. Sender R, Fuchs S, Milo R. Revised Estimates for the Number of Human and Bacteria Cells in the Body. PloS Biol (2016) 14(8):e1002533. 10.1371/journal.pbio.1002533
    1. Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Nageshwar Reddy D. Role of the Normal Gut Microbiota. World J Gastroenterol (2015) 21(29):8787–803. 10.3748/wjg.v21.i29.8787
    1. DeGruttola AK, Low D, Mizoguchi A, Mizoguchi E. Current Understanding of Dysbiosis in Disease in Human and Animal Models. Inflammation Bowel Dis (2016) 22(5):1137–50. 10.1097/MIB.0000000000000750
    1. Gao R, Zhu C, Li H, Yin M, Pan C, Huang L, et al. . Dysbiosis Signatures of Gut Microbiota Along the Sequence From Healthy, Young Patients to Those With Overweight and Obesity. Obes (Silver Spring) (2018) 26(2):351–61. 10.1002/oby.22088
    1. Chassaing B, Raja SM, Lewis JD, Srinivasan S, Gewirtz AT. Colonic Microbiota Encroachment Correlates With Dysglycemia in Humans. Cell Mol Gastroenterol Hepatol (2017) 4(2):205–21. 10.1016/j.jcmgh.2017.04.001
    1. Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, Srinivasan S, et al. . Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5. Science (2010) 328(5975):228–31. 10.1126/science.1179721
    1. Gill PA, van Zelm MC, Muir JG, Gibson PR. Review Article: Short Chain Fatty Acids as Potential Therapeutic Agents in Human Gastrointestinal and Inflammatory Disorders. Aliment Pharmacol Ther (2018) 48(1):15–34. 10.1111/apt.14689
    1. Wu Y, Duan H, Tian X, Xu C, Wang W, Jiang W, et al. . Genetics of Obesity Traits: A Bivariate Genome-Wide Association Analysis. Front Genet (2018) 9:179. 10.3389/fgene.2018.00179
    1. Kasuga M. [Genetic Factor for Diabetes and Obesity]. Nihon Rinsho (2010) 68(Suppl 8):359–63.
    1. Srinivasan S, Chen L, Todd J, Divers J, Gidding S, Chernausek S, et al. . The First Genome-Wide Association Study for Type 2 Diabetes in Youth: The Progress in Diabetes Genetics in Youth (ProDiGY) Consortium. Diabetes (2021) 70:996–1005. 10.2337/db20-0443
    1. Chen J, Sun M, Adeyemo A, Pirie F, Carstensen T, Pomilla C, et al. . Genome-Wide Association Study of Type 2 Diabetes in Africa. Diabetologia (2019) 62:1204–11. 10.1007/s00125-019-4880-7
    1. Bogardus C. Missing Heritability and GWAS Utility. Obes (Silver Spring) (2009) 17(2):209–10. 10.1038/oby.2008.613
    1. Wang T, Xu M, Bi Y, Ning G. Interplay Between Diet and Genetic Susceptibility in Obesity and Related Traits. Front Med (2018) 12(6):601–7. 10.1007/s11684-018-0648-6
    1. Thaker VV. Genetic And Epigenetic Causes Of Obesity. Adolesc Med State Art Rev (2017) 28(2):379–405.
    1. Huvenne H, Dubern B, Clément K, Poitou C. Rare Genetic Forms of Obesity: Clinical Approach and Current Treatments in 2016. Obes Facts (2016) 9(3):158–73. 10.1159/000445061
    1. Czajkowski P, Adamska-Patruno E, Bauer W, Fiedorczuk J, Krasowska U, Moroz M, et al. . The Impact of FTO Genetic Variants on Obesity and Its Metabolic Consequences Is Dependent on Daily Macronutrient Intake. Nutrients (2020) 12(11):3255. 10.3390/nu12113255
    1. Koochakpour G, Esfandiar Z, Hosseini-Esfahani F, Mirmiran P, Daneshpour MS, Sedaghati-Khayat B, et al. . Evaluating the Interaction of Common FTO Genetic Variants, Added Sugar, and Trans-Fatty Acid Intakes in Altering Obesity Phenotypes. Nutr Metab Cardiovasc Dis (2019) 29(5):474–80. 10.1016/j.numecd.2019.01.005
    1. Martins MC, Trujillo J, Freitas-Vilela AA, Farias DR, Rosado EL, Struchiner CJ, et al. . Associations Between Obesity Candidate Gene Polymorphisms (Fat Mass and Obesity-Associated (FTO), Melanocortin-4 Receptor (MC4R), Leptin (LEP) and Leptin Receptor (LEPR)) and Dietary Intake in Pregnant Women. Br J Nutr (2018) 120(4):454–63. 10.1017/S0007114518001423
    1. Yupanqui-Lozno H, Bastarrachea RA, Yupanqui-Velazco ME, Alvarez-Jaramillo M, Medina-Méndez E, Giraldo-Peña AP, et al. . Congenital Leptin Deficiency and Leptin Gene Missense Mutation Found in Two Colombian Sisters With Severe Obesity. Genes (Basel) (2019) 10(5):342. 10.3390/genes10050342
    1. Magno F, Guaraná HC, da Fonseca A, Pedrosa AP, Zembrzuski VM, Cabello PH, et al. . Association of the MC4R Rs17782313 Polymorphism With Plasma Ghrelin, Leptin, IL6 and Tnfα Concentrations, Food Intake and Eating Behaviors in Morbidly Obese Women. Eat Weight Disord (2020) 26(4):1079–87. 10.1007/s40519-020-01003-5
    1. Yu H, Chhabra KH, Thompson Z, Jones GL, Kiran S, Shangguan G, et al. . Hypothalamic POMC Deficiency Increases Circulating Adiponectin Despite Obesity. Mol Metab (2020) 35:100957. 10.1016/j.molmet.2020.01.021
    1. Cunha M, Aparício G, Duarte J, Pereira A, Albuquerque C, Oliveira A. Genetic Heritage as a Risk Factor Enabling Chilhood Obesity. Aten Primaria (2013) 45(Suppl 2):201–7. 10.1016/S0212-6567(13)70023-4
    1. Gupta N, Jain V. Prader Willi Syndrome - A Common Epigenetic Cause of Syndromic Obesity. Indian J Pediatr (2017) 84:809–10. 10.1007/s12098-017-2512-0
    1. Cena H, Chiovato L, Nappi RE. Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists. J Clin Endocrinol Metab (2020) 105(8):e2695–709. 10.1210/clinem/dgaa285
    1. D'Angelo CS, Koiffmann CP. Copy Number Variants in Obesity-Related Syndromes: Review and Perspectives on Novel Molecular Approaches. J Obes (2012) 2012:845480. 10.1155/2012/845480
    1. Rosen ED, Kaestner KH, Natarajan R, Patti ME, Sallari R, Sander M, et al. . Epigenetics and Epigenomics: Implications for Diabetes and Obesity. Diabetes (2018) 67(10):1923–31. 10.2337/db18-0537
    1. Jaenisch R, Bird A. Epigenetic Regulation of Gene Expression: How the Genome Integrates Intrinsic and Environmental Signals. Nat Genet (2003) 33(Suppl):245–54. 10.1038/ng1089
    1. Holmes D. Epigenetics: On-Off Switch for Obesity. Nat Rev Endocrinol (2016) 12(3):125. 10.1038/nrendo.2016.18
    1. Burgio E, Lopomo A, Migliore L. Obesity and Diabetes: From Genetics to Epigenetics. Mol Biol Rep (2015) 42(4):799–818. 10.1007/s11033-014-3751-z
    1. Sherwood WB, Bion V, Lockett GA, Ziyab AH, Soto-Ramírez N, Mukherjee N, et al. . Duration of Breastfeeding Is Associated With Leptin (LEP) DNA Methylation Profiles and BMI in 10-Year-Old Children. Clin Epigenet (2019) 11(1):128. 10.1186/s13148-019-0727-9
    1. Houde AA, Légaré C, Biron S, Lescelleur O, Biertho L, Marceau S, et al. . Leptin and Adiponectin DNA Methylation Levels in Adipose Tissues and Blood Cells are Associated With BMI, Waist Girth and LDL-Cholesterol Levels in Severely Obese Men and Women. BMC Med Genet (2015) 16:29. 10.1186/s12881-015-0174-1
    1. Soubry A, Schildkraut JM, Murtha A, Wang F, Huang Z, Bernal A, et al. . Paternal Obesity is Associated With IGF2 Hypomethylation in Newborns: Results From a Newborn Epigenetics Study (NEST) Cohort. BMC Med (2013) 11:29. 10.1186/1741-7015-11-29
    1. Bannister AJ, Kouzarides T. Regulation of Chromatin by Histone Modifications. Cell Res (2011) 21(3):381–95. 10.1038/cr.2011.22
    1. Zhang Q, Ramlee MK, Brunmeir R, Villanueva CJ, Halperin D, Xu F. Dynamic and Distinct Histone Modifications Modulate the Expression of Key Adipogenesis Regulatory Genes. Cell Cycle (2012) 11(23):4310–22. 10.4161/cc.22224
    1. Funato H, Oda S, Yokofujita J, Igarashi H, Kuroda M. Fasting and High-Fat Diet Alter Histone Deacetylase Expression in the Medial Hypothalamus. PloS One (2011) 6(4):e18950. 10.1371/journal.pone.0018950
    1. Pasquinelli AE. MicroRNAs and Their Targets: Recognition, Regulation and an Emerging Reciprocal Relationship. Nat Rev Genet (2012) 13(4):271–82. 10.1038/nrg3162
    1. Cruz K, de Oliveira A, Morais J, Severo JS, Marreiro D. Role of microRNAs on Adipogenesis, Chronic Low-Grade Inflammation, and Insulin Resistance in Obesity. Nutrition (2017) 35:28–35. 10.1016/j.nut.2016.10.003
    1. Zhao H, Shen J, Daniel-MacDougall C, Wu X, Chow WH. Plasma MicroRNA Signature Predicting Weight Gain Among Mexican-American Women. Obes (Silver Spring) (2017) 25(5):958–64. 10.1002/oby.21824
    1. Hubal MJ, Nadler EP, Ferrante SC, Barberio MD, Suh JH, Wang J, et al. . Circulating Adipocyte-Derived Exosomal MicroRNAs Associated With Decreased Insulin Resistance After Gastric Bypass. Obes (Silver Spring) (2017) 25(1):102–10. 10.1002/oby.21709
    1. Guidelines (2013) for Managing Overweight and Obesity in Adults. Preface to the Expert Panel Report (Comprehensive Version Which Includes Systematic Evidence Review, Evidence Statements, and Recommendations). Obes (Silver Spring) (2014) 22 Suppl 2:S40. 10.1002/oby.20822
    1. Lee EY, Yoon KH. Epidemic Obesity in Children and Adolescents: Risk Factors and Prevention. Front Med (2018) 12(6):658–66. 10.1007/s11684-018-0640-1
    1. Nguyen B, Clements J. Obesity Management Among Patients With Type 2 Diabetes and Prediabetes: A Focus on Lifestyle Modifications and Evidence of Antiobesity Medications. Expert Rev Endocrinol Metab (2017) 12(5):303–13. 10.1080/17446651.2017.1367285
    1. Mozaffarian D, Hao T, Rimm EB, Willett WC, Hu FB. Changes in Diet and Lifestyle and Long-Term Weight Gain in Women and Men. N Engl J Med (2011) 364(25):2392–404. 10.1056/NEJMoa1014296
    1. Struben J, Chan D, Dubé L. Policy Insights From the Nutritional Food Market Transformation Model: The Case of Obesity Prevention. Ann N Y Acad Sci (2014) 1331:57–75. 10.1111/nyas.12381
    1. Lal A, Mantilla-Herrera AM, Veerman L, Backholer K, Sacks G, Moodie M, et al. . Correction: Modelled Health Benefits of a Sugar-Sweetened Beverage Tax Across Different Socioeconomic Groups in Australia: A Cost-Effectiveness and Equity Analysis. PloS Med (2020) 17(7):e1003310. 10.1371/journal.pmed.1003310
    1. Telles S, Gangadhar BN, Chandwani KD. Lifestyle Modification in the Prevention and Management of Obesity. J Obes (2016) 2016:5818601. 10.1155/2016/5818601
    1. Greenway FL, Aronne LJ, Raben A, Astrup A, Apovian CM, Hill JO, et al. . A Randomized, Double-Blind, Placebo-Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss. Obes (Silver Spring) (2019) 27:205–16. 10.1002/oby.22347
    1. Yeo G, Chao D, Siegert AM, Koerperich ZM, Ericson MD, Simonds SE, et al. . The Melanocortin Pathway and Energy Homeostasis: From Discovery to Obesity Therapy. Mol Metab (2021) 48:101206. 10.1016/j.molmet.2021.101206
    1. Gomez G, Stanford FC. US Health Policy and Prescription Drug Coverage of FDA-Approved Medications for the Treatment of Obesity. Int J Obes (Lond) (2018) 42(3):495–500. 10.1038/ijo.2017.287
    1. Rebello CJ, Greenway FL. Obesity Medications in Development. Expert Opin Investig Drugs (2020) 29:63–71. 10.1080/13543784.2020.1705277
    1. Karri S, Sharma S, Hatware K, Patil K. Natural Anti-Obesity Agents and Their Therapeutic Role in Management of Obesity: A Future Trend Perspective. BioMed Pharmacother (2019) 110:224–38. 10.1016/j.biopha.2018.11.076
    1. Gong S, Ye T, Wang M, Wang M, Li Y, Ma L, et al. . Traditional Chinese Medicine Formula Kang Shuai Lao Pian Improves Obesity, Gut Dysbiosis, and Fecal Metabolic Disorders in High-Fat Diet-Fed Mice. Front Pharmacol (2020) 11:297. 10.3389/fphar.2020.00297
    1. Aminian A, Zelisko A, Kirwan JP, Brethauer SA, Schauer PR. Exploring the Impact of Bariatric Surgery on High Density Lipoprotein. Surg Obes Relat Dis (2015) 11:238–47. 10.1016/j.soard.2014.07.017
    1. Osto M, Abegg K, Bueter M, le Roux CW, Cani PD, Lutz TA. Roux-En-Y Gastric Bypass Surgery in Rats Alters Gut Microbiota Profile Along the Intestine. Physiol Behav (2013) 119:92–6. 10.1016/j.physbeh.2013.06.008
    1. Al-Rubaye H, McGlone ER, Farzaneh B, Mustafa L, Johnson M, Kayal A, et al. . Roux-En-Y Gastric Bypass or Sleeve Gastrectomy for Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis. Laparoscopic Endoscopic Robotic Surg (2019) 2(3):53–8. 10.1016/j.lers.2019.05.002
    1. Kops NL, Vivan MA, Fülber ER, Fleuri M, Fagundes J, Friedman R. Preoperative Binge Eating and Weight Loss After Bariatric Surgery: A Systematic Review and Meta-Analysis. Obes Surg (2020) 31(3):1239–48. 10.1007/s11695-020-05124-9
    1. Kong LC, Tap J, Aron-Wisnewsky J, Pelloux V, Basdevant A, Bouillot JL, et al. . Gut Microbiota After Gastric Bypass in Human Obesity: Increased Richness and Associations of Bacterial Genera With Adipose Tissue Genes. Am J Clin Nutr (2013) 98(1):16–24. 10.3945/ajcn.113.058743
    1. Zhang H, DiBaise JK, Zuccolo A, Kudrna D, Braidotti M, Yu Y, et al. . Human Gut Microbiota in Obesity and After Gastric Bypass. Proc Natl Acad Sci USA (2009) 106(7):2365–70. 10.1073/pnas.0812600106
    1. van Leiden HA, Dekker JM, Moll AC, Nijpels G, Heine RJ, Bouter LM, et al. . Blood Pressure, Lipids, and Obesity are Associated With Retinopathy: The Hoorn Study. Diabetes Care (2002) 25(8):1320–5. 10.2337/diacare.25.8.1320
    1. Yu EW, Gao L, Stastka P, Cheney MC, Mahabamunuge J, Torres Soto M, et al. . Fecal Microbiota Transplantation for the Improvement of Metabolism in Obesity: The FMT-TRIM Double-Blind Placebo-Controlled Pilot Trial. PloS Med (2020) 17(3):e1003051. 10.1371/journal.pmed.1003051
    1. Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL, et al. . Gut Microbiota From Twins Discordant for Obesity Modulate Metabolism in Mice. Science (2013) 341(6150):1241214. 10.1126/science.1241214
    1. Vrieze A, Van Nood E, Holleman F, Salojärvi J, Kootte RS, Bartelsman JF, et al. . Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome. Gastroenterology (2012) 143(4):913–6.e7. 10.1053/j.gastro.2012.06.031
    1. Zhang Z, Mocanu V, Cai C, Dang J, Slater L, Deehan EC, et al. . Impact of Fecal Microbiota Transplantation on Obesity and Metabolic Syndrome-A Systematic Review. Nutrients (2019) 11(10):2291. 10.3390/nu11102291
    1. Phan HD, Nguyen T, Bui PL, Pham TT, Doan TV, Nguyen, et al. . Overweight and Obesity Among Vietnamese School-Aged Children: National Prevalence Estimates Based on the World Health Organization and International Obesity Task Force Definition. PloS One (2020) 15(10):e0240459. 10.1371/journal.pone.0240459
    1. Epigenetic Drugs. Nat Biotechnol (2020) 38(5):558. 10.1038/s41587-020-0523-2
    1. Arguelles AO, Meruvu S, Bowman JD, Choudhury M. Are Epigenetic Drugs for Diabetes and Obesity at Our Door Step. Drug Discov Today (2016) 21(3):499–509. 10.1016/j.drudis.2015.12.001
    1. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial Ecology: Human Gut Microbes Associated With Obesity. Nature (2006) 444(7122):1022–3. 10.1038/4441022a

Source: PubMed

3
S'abonner